Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.
01 1Farmak, a,s
02 1Dr.Reddy's Laboratories Limited
03 1Chromo Laboratories India Private Limited
04 1Fagron Inc
05 1LETCO MEDICAL, LLC
06 1MSN Laboratories Private Limited
07 1Medisca Inc.
08 2Professional Compounding Centers of America dba PCCA
09 1Quimica Sintetica S.A.
10 1RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA
11 1SCL Healthsciences Limited
12 1Spectrum Laboratory Products, Inc.
13 1Symed Labs Limited
14 2Vasudha Pharma Chem Limited
01 1KETORLAC TROMETHAMINE
02 4KETOROLAC TROMETHAMINE
03 11Ketorolac Tromethamine
01 1Czech Republic
02 6India
03 1Italy
04 1Netherlands
05 1Spain
06 2U.S.A
07 2United Kingdom
08 2Blank
Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.
NDC Package Code : 63278-1056
Start Marketing Date : 2000-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-014
Start Marketing Date : 1999-11-23
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51552-1371
Start Marketing Date : 2011-10-31
End Marketing Date : 2027-07-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 14501-0010
Start Marketing Date : 2010-03-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-0111
Start Marketing Date : 2019-03-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-3443
Start Marketing Date : 2002-06-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 12711-5990
Start Marketing Date : 2010-07-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 49452-3926
Start Marketing Date : 2019-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-2249
Start Marketing Date : 2012-01-30
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
NDC Package Code : 43235-0001
Start Marketing Date : 2017-07-07
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
44
PharmaCompass offers a list of Ketorolac Trometamol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ketorolac Trometamol manufacturer or Ketorolac Trometamol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ketorolac Trometamol manufacturer or Ketorolac Trometamol supplier.
PharmaCompass also assists you with knowing the Ketorolac Trometamol API Price utilized in the formulation of products. Ketorolac Trometamol API Price is not always fixed or binding as the Ketorolac Trometamol Price is obtained through a variety of data sources. The Ketorolac Trometamol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A ketorolac; tris buffer manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of ketorolac; tris buffer, including repackagers and relabelers. The FDA regulates ketorolac; tris buffer manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. ketorolac; tris buffer API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of ketorolac; tris buffer manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A ketorolac; tris buffer supplier is an individual or a company that provides ketorolac; tris buffer active pharmaceutical ingredient (API) or ketorolac; tris buffer finished formulations upon request. The ketorolac; tris buffer suppliers may include ketorolac; tris buffer API manufacturers, exporters, distributors and traders.
click here to find a list of ketorolac; tris buffer suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing ketorolac; tris buffer as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for ketorolac; tris buffer API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture ketorolac; tris buffer as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain ketorolac; tris buffer and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a ketorolac; tris buffer NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of ketorolac; tris buffer suppliers with NDC on PharmaCompass.
We have 12 companies offering ketorolac; tris buffer
Get in contact with the supplier of your choice:
